Acute Iron Dextran Injection Increases Liver Weight and Reduces Glycerol Kinase Expression in Liver

Ramdan Panigoro, Fadhal M. Ahmad, Uni Gamayani, Neni Anggraeni, Rini Widyastuti, Mohammad Ghozali, Mas Rizky A.A Syamsunarno

Abstract


Iron is essential and needed in a very small amount. When iron exceeds normal need, metabolic alteration occurs, causing hepatosteatosis. The mechanism of iron inducing hepatosteatosis remains unclear. Glycerol kinase, the enzyme responsible in triglyceride synthesis initiation, is assumed to have a role in the pathomechanism of hepatosteatosis. This study aimed to investigate the gene expression of glycerol kinase in an acute iron overload condition. This study was conducted in Animal Laboratory Faculty of Medicine and Central Laboratory Universitas Padjadjaran from May to June 2017. Three groups of mice were divided by the dose of iron dextran injection (0, 0.1, 0.3 mg/day/mice). After 19 days, mice were terminated, liver weight was measured and glycerol kinase gene expression in the liver was determined by semi-qualitative PCR. Quantification of PCR result was calculated by ImageJ software. There was a significant change in liver weight of the mice in a dose-dependent manner of iron injection. The expression of glycerol kinase tended to decrease, but statistically insignificant. Acute iron dextran injection increases liver weight and tends to reduce glycerol kinase gene expression in mice liver.

Keywords: Glycerol kinase, hepatosteatosis, iron overload

 

Efek Zat Besi Dosis Tinggi Akut dalam Meningkatkan Berat Organ dan Menurunkan Ekspresi Gliserol Kinase Hepar

Abstrak
Zat besi merupakan nutrien esensial dan diperlukan dalam jumlah yang sangat kecil. Ketika kadar zat besi melebihi kadar normal dalam tubuh, terjadi perubahan metabolisme yang menyebabkan hepatosteatosis. Mekanisme zat besi dalam menyebabkan hepatosteatosis masih belum diketahui secara pasti. Gliserol kinase, enzim yang menginisiasi sintesis trigliserida, diduga berperan dalam patomekanisme hepatosteatosis. Penelitian ini bertujuan untuk meneliti ekspresi gen gliserol kinase pada hepar pada kondisi tinggi zat besi akut. Penelitian ini dilakukan di Laboratorium Hewan Fakultas Kedokteran dan Laboratorium Sentral Universitas Padjadjaran dari bulan Mei sampai dengan Juni 2017. Tiga kelompok mencit dibagi berdasarkan dosis injeksi iron dextran intraperitoneal (0, 0,1, 0,3 mg/hari/ekor). Setelah 19 hari, mencit diterminasi, berat hepar ditimbang dan ekspresi gen gliserol kinase diukur dengan metode semi-kualitatif PCR. Kuantifikasi hasil PCR dilakukan dengan menggunakan aplikasi ImageJ. Terdapat peningkatan berat hepar secara signifikan yang sejalan dengan dosis ijeksi zat besi. Ekspresi gen gliserol kinase cenderung menurun, meskipun secara statistik tidak signifikan. Keadaan tinggi kadar zat besi yang akut meningkatkan berat hepar dan cenderung menurunkan ekspresi gen gliserol kinase pada hepar mencit.

Kata kunci: Gliserol kinase, hepatosteatosis, zat besi berlebih


Keywords


Glycerol kinase, hepatosteatosis, iron overload

Full Text:

PDF

References


Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014;19(2):164–74.

Kohgo Y, Ikuta ÆK, Ohtake ÆT. Body iron metabolism and pathophysiology of iron overload. 2008;88(1):7–15. doi: 10.1007/s12185-008-0120-5]

Oliveira F, Rocha S, Fernandes R. Iron metabolism: From health to disease. J Clin Lab Anal. 2014;28(3):210–8. doi: 10.1002/jcla.21668

Meroño T, Rosso LG, Sorroche P, Boero L, Arbelbide J, Brites F. High risk of cardiovascular disease in iron overload patients. Eur J Clin Invest. 2011;41(5):479–86. doi: 10.1111/j.1365-2362.2010.02429.x.

Berdoukas V, Farmaki K, Carson S, Wood J, Coates T. Treating thalassemia major-related iron overload: The role of deferiprone. J Blood Med. 2012;3:119–29. doi: 10.2147/JBM.S27400

Anderson ER, Shah YM. Iron homeostasis in the liver. Compr Physiol. 2013;3(1):315–30. doi: 10.1002/cphy.c120016.

Saito H. Metabolism of iron stores. Nagoya J Med Sci. 2014;76(3–4):235–54.

Sengsuk C, Tangvarasittichai O, Chantanaskulwong P, Pimanprom A, Wantaneeyawong S, Choowet A, et al. Association of iron overload with oxidative stress, hepatic damage and dyslipidemia in transfusion-dependent β-thalassemia/HbE patients. Indian J Clin Biochem. 2014;29(3):298–305. doi: 10.1007/s12291-013-0376-2

Gao X, Campian JL, Qian M, Sun XF, Eaton JW. Mitochondrial DNA damage in iron overload. J Biol Chem. 2009;284(8):4767–75. doi: 10.1074/jbc.M806235200

Plowman S, Smith DL. Energy production. Exerc Physiol Heal Fit Perform. 2011;18:26–54.

Ahmed U, Latham PS, Oates PS. Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis. World J Gastroenterol. 2012;18(34):4651–8. doi: 10.3748/wjg.v18.i34.4651

Parisi GF, Di Dio G, Franzonello C, Gennaro A, Rotolo N, Lionetti E, et al. Liver disease in cystic fibrosis: An update. Hepat Mon. 2013;13(8):e11215. doi: 10. 812/hepatmon.11215]

Udipi S, Ghugre P, Gokhale C. Iron, oxidative stress and health. In: Oxidative stress–molecular mechanisms and biological effects. InTech. 2012;73–108. doi: 10.5772/34975

Gena P, Mastrodonato M, Portincasa P, Fanelli E, Mentino D, Rodríguez A, et al. Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of non-alcoholic fatty liver disease. PLoS One. 2013;8(10):e78139. doi: 10.1371/journal.pone.0078139

Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology. 2004;40(6):1387–95. doi: 10.1002/hep.20466

Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, Colloredo G, et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient data. Gastroenterology. 2006;130(6):1636–42. doi: 10.1053/j.gastro.2006.03.014

Koopman KE, Caan MWA, Nederveen AJ, Pels A, Ackermans MT, Fliers E, et al. Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: A randomized controlled trial. Hepatology. 2014;60(2):545–53. doi: 10.1002/hep.27149

Ress C, Kaser S. Mechanisms of intrahepatic triglyceride accumulation. World J Gastroenterol. 2016;22(4):1664–73. doi: 10.3748/wjg.v22.i4.1664.

Lipid Home. Tracylglycerols: Biosynthesis and metabolism [Accessed on: 23rd August 2017]. Available at: http://www.lipidhom e.co.uk/lipids/simple/tag2/index.htm

UniProt. Glycerol kinase protein [Accessed on: 23rd August 2017]. Available at: http://www.uniprot.org/uniprot/P32189

Sari SP, Syamsunarno MRAA, Susanah S, Atik N, Ghozali M, Safitri R, et al. The effect of excess iron on the impairment of glucose metabolism in mice. J Biomed Clin Sci. 2017;2(2):8–10.

Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis historical commentary. Nat Methods. 2012;9(7):671–5.

Nelson JE, Wilson L, Brunt EM, Yeh MM, David E, Unalp-arida A, et al. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology. 2011;53(2):448–57. doi: 10.1002/hep.24038.

Nelson JE, Klintworth H, Kowdley KV. Iron metabolism in nonalcoholic fatty liver disease. Curr Gastroenterol Rep. 2012;14(1):8–16. doi: 10.1007/s11894-011-0234-4.

Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ.. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343–51. doi: 10.1172/JCI23621

Syamsunarno MRAA, Iso T, Hanaoka H, Yamaguchi A, Obokata M, Koitabashi N, et al. A critical role of fatty acid binding protein 4 and 5 (FABP4/5) in the systemic response to fasting. PLoS One. 2013;8(11):e79386. doi: 10.1371/journal.pone.0079386.

Milic S, Mikolasevic I, Orlic L, Devcic E, Starcevic-Cizmarevic N, Stimac D, et al. The role of iron and iron overload in chronic liver disease. Med Sci Monit. 2016;22:2144–51. doi: 10.12659/MSM.896494

Shams S, Ashtiani MTH, Monajemzadeh M, Koochakzadeh L, Irani H, Jafari F, et al. Evaluation of serum insulin, glucose, lipid profile, and liver function in β-thalassemia major patients and their correlation with iron overload. Lab Med. 2010;41(8):486–9. doi: 10.1309/LMS0EOOUZSII2BNE




DOI: https://doi.org/10.15416/ijcp.2018.7.4.236

Refbacks

  • There are currently no refbacks.


 Indonesian Journal of Clinical Pharmacy is indexed by

        

  Creative Commons License

IJCP by Universitas Padjadjaran is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 

View My Stats